NEBIVOLOL HYDROCHLORIDE

NEBIVOLOL HYDROCHLORIDE was reported 34143 times

NEBIVOLOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THERAPEUTIC DRUG MONITORING ANALYSIS NOT PERFORMED 21 0.0712
1 HYPOPARATHYROIDISM 29 0.0378
2 ORTHOSTATIC INTOLERANCE 27 0.0376
3 PRODUCT MONITORING ERROR 34 0.0235
4 VASCULAR PURPURA 31 0.0222
5 HAEMATOMA MUSCLE 25 0.0209
6 NEPHROGENIC ANAEMIA 93 0.0201
7 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 21 0.0198
8 SYSTEMIC INFECTION 31 0.0187
9 OBSTRUCTIVE SLEEP APNOEA SYNDROME 27 0.0185
10 HYPERPARATHYROIDISM SECONDARY 44 0.0175
11 OSTEOCHONDROSIS 20 0.0172
12 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 24 0.0171
13 GLOMERULAR FILTRATION RATE ABNORMAL 24 0.0169
14 BLADDER TRANSITIONAL CELL CARCINOMA 24 0.0167
15 CUTANEOUS LUPUS ERYTHEMATOSUS 32 0.0165
16 SINUS ARREST 24 0.0153
17 PERIPHERAL MOTOR NEUROPATHY 21 0.0150
18 NORMOCYTIC ANAEMIA 21 0.0143
19 CEREBRAL HAEMATOMA 48 0.0143
20 ESSENTIAL HYPERTENSION 26 0.0142
21 ACTINIC KERATOSIS 36 0.0139
22 HYPOMAGNESAEMIA 182 0.0131
23 POTENTIATING DRUG INTERACTION 43 0.0128
24 SINUS NODE DYSFUNCTION 23 0.0125
25 HYPERTENSIVE CRISIS 138 0.0124
26 AKINESIA 25 0.0121
27 HAEMORRHAGIC ANAEMIA 53 0.0120
28 SPRUE-LIKE ENTEROPATHY 59 0.0120
29 REBOUND ACID HYPERSECRETION 36 0.0119
30 AORTIC VALVE STENOSIS 21 0.0118
31 RENAL TUBULAR DISORDER 33 0.0117
32 MONOPARESIS 21 0.0116
33 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 100 0.0113
34 HYPERKALAEMIA 385 0.0110
35 POLYCYTHAEMIA 22 0.0107
36 MICROCYTIC ANAEMIA 22 0.0106
37 DIABETIC NEPHROPATHY 23 0.0104
38 CARDIAC FAILURE CHRONIC 44 0.0103
39 CORONARY ARTERY STENOSIS 51 0.0101
40 BRADYCARDIA 516 0.0097
41 ATRIAL TACHYCARDIA 20 0.0095
42 RETROPERITONEAL HAEMATOMA 21 0.0095
43 BLOOD PRESSURE INADEQUATELY CONTROLLED 56 0.0093
44 EXTRASYSTOLES 64 0.0092
45 LICHEN PLANUS 21 0.0090
46 BLOOD CREATININE ABNORMAL 31 0.0090
47 CRANIOCEREBRAL INJURY 27 0.0089
48 ATRIOVENTRICULAR BLOCK 68 0.0088
49 PERIARTHRITIS 20 0.0088
50 ACUTE KIDNEY INJURY 1345 0.0088
51 VITAMIN B12 DECREASED 25 0.0087
52 ELECTROCARDIOGRAM ABNORMAL 68 0.0087
53 BLOOD POTASSIUM ABNORMAL 23 0.0086
54 SUPRAVENTRICULAR EXTRASYSTOLES 29 0.0086
55 END STAGE RENAL DISEASE 156 0.0085
56 MIGRAINE WITH AURA 23 0.0085
57 URINE OUTPUT INCREASED 22 0.0084
58 GASTROINTESTINAL MOTILITY DISORDER 45 0.0084
59 SKIN EROSION 27 0.0084
60 EXERCISE TOLERANCE DECREASED 48 0.0083
61 WRONG PATIENT RECEIVED PRODUCT 24 0.0082
62 HYPOCALCAEMIA 155 0.0082
63 HYPOVOLAEMIC SHOCK 38 0.0079
64 ATRIOVENTRICULAR BLOCK COMPLETE 53 0.0079
65 ORTHOSTATIC HYPOTENSION 137 0.0079
66 CHONDROPATHY 21 0.0077
67 LACTIC ACIDOSIS 247 0.0076
68 SHOCK HAEMORRHAGIC 62 0.0076
69 ANGINA PECTORIS 216 0.0075
70 SPINAL OSTEOARTHRITIS 66 0.0075
71 VENTRICULAR EXTRASYSTOLES 78 0.0075
72 DIASTOLIC DYSFUNCTION 23 0.0074
73 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 30 0.0073
74 TONGUE OEDEMA 28 0.0073
75 HAEMORRHAGIC STROKE 57 0.0073
76 KIDNEY TRANSPLANT REJECTION 35 0.0073
77 GASTRITIS EROSIVE 34 0.0073
78 HYPONATRAEMIA 409 0.0073
79 CHOLESTASIS 138 0.0072
80 ISCHAEMIC STROKE 128 0.0072
81 SNORING 27 0.0071
82 SINUS BRADYCARDIA 69 0.0071
83 CUTANEOUS VASCULITIS 26 0.0071
84 HYPOKALAEMIA 328 0.0071
85 HYPERLACTACIDAEMIA 19 0.0071
86 STAPHYLOCOCCAL BACTERAEMIA 30 0.0069
87 ESCHERICHIA SEPSIS 20 0.0069
88 BUNDLE BRANCH BLOCK LEFT 29 0.0068
89 TUBULOINTERSTITIAL NEPHRITIS 127 0.0068
90 LEFT VENTRICULAR FAILURE 23 0.0067
91 METABOLIC ENCEPHALOPATHY 20 0.0067
92 DIVERTICULUM INTESTINAL 29 0.0066
93 LIP OEDEMA 28 0.0066
94 CHRONIC KIDNEY DISEASE 501 0.0066
95 FEBRILE BONE MARROW APLASIA 28 0.0066
96 AORTIC VALVE INCOMPETENCE 28 0.0066
97 PRE-EXISTING CONDITION IMPROVED 41 0.0066
98 EOSINOPHILIA 115 0.0066
99 COLITIS MICROSCOPIC 31 0.0065
100 TRICUSPID VALVE INCOMPETENCE 52 0.0065
101 ELECTROLYTE IMBALANCE 76 0.0065
102 VENTRICULAR HYPOKINESIA 21 0.0065
103 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 67 0.0065
104 BRAIN NATRIURETIC PEPTIDE INCREASED 20 0.0065
105 HEART RATE DECREASED 225 0.0064
106 EPIGASTRIC DISCOMFORT 25 0.0064
107 GLOMERULAR FILTRATION RATE DECREASED 78 0.0063
108 IDIOPATHIC PULMONARY FIBROSIS 25 0.0063
109 AORTIC STENOSIS 22 0.0063
110 CONGESTIVE CARDIOMYOPATHY 26 0.0062
111 ACUTE PULMONARY OEDEMA 35 0.0062
112 MENISCUS INJURY 38 0.0062
113 ANURIA 53 0.0062
114 MELAENA 135 0.0061
115 PERIPHERAL VENOUS DISEASE 25 0.0061
116 NOCTURIA 74 0.0061
117 BLOOD LACTIC ACID INCREASED 32 0.0061
118 OESOPHAGITIS 66 0.0060
119 MALABSORPTION 31 0.0059
120 HEPATOCELLULAR INJURY 84 0.0059
121 LEFT VENTRICULAR HYPERTROPHY 25 0.0058
122 HYPERURICAEMIA 24 0.0058
123 RENAL FUNCTION TEST ABNORMAL 27 0.0058
124 CAROTID ARTERY STENOSIS 20 0.0057
125 BLOOD URIC ACID INCREASED 33 0.0057
126 ACUTE CORONARY SYNDROME 47 0.0057
127 SOPOR 75 0.0057
128 FACIAL PARESIS 20 0.0056
129 HEPATIC CYTOLYSIS 72 0.0056
130 HAEMORRHAGIC DIATHESIS 20 0.0056
131 BLOOD PRESSURE INCREASED 853 0.0056
132 PEMPHIGOID 42 0.0056
133 CARDIAC FAILURE ACUTE 37 0.0055
134 PRESYNCOPE 135 0.0055
135 DUODENAL ULCER 39 0.0055
136 IRON DEFICIENCY ANAEMIA 51 0.0055
137 AZOTAEMIA 22 0.0055
138 CARDIOGENIC SHOCK 79 0.0055
139 POLYURIA 45 0.0055
140 FAECALOMA 30 0.0055
141 MELANOCYTIC NAEVUS 24 0.0055
142 VENTRICULAR ARRHYTHMIA 20 0.0055
143 GOUT 98 0.0055
144 MITRAL VALVE INCOMPETENCE 61 0.0054
145 GLOSSITIS 19 0.0053
146 DIVERTICULUM 38 0.0053
147 THYROID FUNCTION TEST ABNORMAL 22 0.0053
148 BLOOD THYROID STIMULATING HORMONE DECREASED 24 0.0053
149 ARTERIOSCLEROSIS CORONARY ARTERY 35 0.0053
150 TROPONIN INCREASED 40 0.0053
151 SMALL FOR DATES BABY 26 0.0052
152 BLOOD PRESSURE ABNORMAL 104 0.0052
153 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
154 INTERNATIONAL NORMALISED RATIO DECREASED 21 0.0052
155 ESCHERICHIA URINARY TRACT INFECTION 22 0.0052
156 PERIPHERAL COLDNESS 71 0.0052
157 METABOLIC ACIDOSIS 165 0.0052
158 RECALLED PRODUCT ADMINISTERED 49 0.0051
159 MUSCLE RUPTURE 20 0.0051
160 DYSLIPIDAEMIA 26 0.0051
161 DRUG INTERACTION 810 0.0051
162 INFLAMMATORY MARKER INCREASED 25 0.0050
163 HYPOTENSION 1005 0.0050
164 SQUAMOUS CELL CARCINOMA 47 0.0050
165 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 128 0.0050
166 ENURESIS 20 0.0049
167 CORONARY ARTERIAL STENT INSERTION 25 0.0049
168 URINE OUTPUT DECREASED 43 0.0049
169 BLOOD PRESSURE FLUCTUATION 118 0.0049
170 HAEMATOMA 127 0.0049
171 RENAL FAILURE 646 0.0049
172 CACHEXIA 25 0.0049
173 POISONING DELIBERATE 46 0.0048
174 PANCREATITIS ACUTE 108 0.0048
175 RHABDOMYOLYSIS 200 0.0048
176 BUNDLE BRANCH BLOCK RIGHT 22 0.0048
177 ONYCHOMYCOSIS 21 0.0048
178 SYNCOPE 476 0.0048
179 CATHETERISATION CARDIAC 21 0.0047
180 AORTIC ANEURYSM 36 0.0047
181 DYSPNOEA EXERTIONAL 177 0.0047
182 ANAEMIA 896 0.0047
183 COVID-19 PNEUMONIA 55 0.0047
184 RALES 27 0.0046
185 GOITRE 19 0.0046
186 PROTEIN URINE PRESENT 23 0.0046
187 CARDIAC FAILURE 368 0.0046
188 HYPERCHOLESTEROLAEMIA 44 0.0046
189 ATRIAL FIBRILLATION 443 0.0045
190 RASH MACULO-PAPULAR 101 0.0045
191 GASTRIC ULCER HAEMORRHAGE 25 0.0045
192 SLEEP APNOEA SYNDROME 86 0.0045
193 HAEMORRHOIDAL HAEMORRHAGE 22 0.0045
194 HYPERTENSION 950 0.0045
195 ACUTE MYOCARDIAL INFARCTION 132 0.0045
196 ABSCESS LIMB 19 0.0045
197 UPPER GASTROINTESTINAL HAEMORRHAGE 75 0.0045
198 HYPOGLYCAEMIA 215 0.0044
199 RENAL CYST 35 0.0044
200 BLOOD TESTOSTERONE DECREASED 30 0.0044
201 CORONAVIRUS INFECTION 29 0.0044
202 VASCULITIS 51 0.0044
203 CORONARY ARTERY OCCLUSION 60 0.0044
204 ERECTILE DYSFUNCTION 112 0.0044
205 ISCHAEMIA 20 0.0043
206 HIATUS HERNIA 56 0.0043
207 NEPHROPATHY 40 0.0043
208 ABNORMAL LOSS OF WEIGHT 29 0.0042
209 SUDDEN DEATH 45 0.0042
210 ARTERIOSCLEROSIS 40 0.0042
211 ECCHYMOSIS 29 0.0042
212 OEDEMA PERIPHERAL 515 0.0042
213 EPISTAXIS 316 0.0042
214 LYMPHOEDEMA 29 0.0042
215 BLOOD TRIGLYCERIDES INCREASED 74 0.0042
216 BLOOD POTASSIUM INCREASED 68 0.0042
217 MUSCULOSKELETAL DISCOMFORT 72 0.0042
218 INTERNATIONAL NORMALISED RATIO INCREASED 119 0.0042
219 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 216 0.0041
220 MYOCARDIAL ISCHAEMIA 47 0.0041
221 POLYP 27 0.0041
222 RENAL IMPAIRMENT 346 0.0041
223 HYPOTONIA 41 0.0041
224 HAEMORRHOIDS 80 0.0041
225 BLOOD SODIUM DECREASED 77 0.0041
226 ARTERIAL OCCLUSIVE DISEASE 32 0.0041
227 HAEMODYNAMIC INSTABILITY 31 0.0041
228 TRANSIENT ISCHAEMIC ATTACK 137 0.0041
229 BLOOD MAGNESIUM DECREASED 35 0.0041
230 EYELID OEDEMA 47 0.0040
231 SINUS HEADACHE 24 0.0040
232 BURSITIS 49 0.0040
233 AGRANULOCYTOSIS 75 0.0040
234 PULMONARY MASS 60 0.0040
235 PETECHIAE 42 0.0040
236 LOW DENSITY LIPOPROTEIN INCREASED 31 0.0040
237 HEPATITIS ACUTE 26 0.0040
238 DEFAECATION URGENCY 28 0.0040
239 CORONARY ARTERY DISEASE 121 0.0040
240 BRONCHOSPASM 57 0.0040
241 DRUG LEVEL INCREASED 66 0.0040
242 BLOOD CREATININE INCREASED 260 0.0040
243 RECTAL HAEMORRHAGE 171 0.0040
244 ERYSIPELAS 20 0.0040
245 TOXIC SKIN ERUPTION 40 0.0040
246 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 20 0.0039
247 SUBDURAL HAEMATOMA 56 0.0039
248 UROSEPSIS 36 0.0039
249 VITAMIN D DEFICIENCY 38 0.0039
250 TENDON RUPTURE 48 0.0039
251 CONCUSSION 30 0.0039
252 VERTIGO 236 0.0039
253 MICTURITION URGENCY 44 0.0038
254 FACIAL PAIN 34 0.0038
255 GENERAL PHYSICAL HEALTH DETERIORATION 438 0.0038
256 HEART RATE ABNORMAL 21 0.0038
257 HYPERLIPIDAEMIA 45 0.0038
258 INTERSTITIAL LUNG DISEASE 182 0.0038
259 BODY HEIGHT DECREASED 40 0.0037
260 RESTLESS LEGS SYNDROME 68 0.0037
261 GASTRIC ULCER 71 0.0037
262 BASAL CELL CARCINOMA 58 0.0037
263 PYELONEPHRITIS 32 0.0037
264 ACUTE RESPIRATORY FAILURE 71 0.0037
265 POLYNEUROPATHY 44 0.0037
266 EJECTION FRACTION DECREASED 57 0.0037
267 HYPERTHYROIDISM 53 0.0037
268 HEPATIC STEATOSIS 68 0.0036
269 CIRCULATORY COLLAPSE 62 0.0036
270 HAEMATOCRIT DECREASED 72 0.0036
271 APHTHOUS ULCER 28 0.0036
272 TACHYPNOEA 49 0.0036
273 JOINT DISLOCATION 38 0.0036
274 ANGIOEDEMA 159 0.0036
275 VENTRICULAR TACHYCARDIA 59 0.0036
276 PRODUCT ADMINISTRATION INTERRUPTED 28 0.0036
277 URINARY RETENTION 119 0.0036
278 GAMMA-GLUTAMYLTRANSFERASE INCREASED 79 0.0036
279 CONCOMITANT DISEASE AGGRAVATED 22 0.0036
280 HYPERCALCAEMIA 44 0.0036
281 PULMONARY HYPERTENSION 74 0.0035
282 SUPRAVENTRICULAR TACHYCARDIA 34 0.0035
283 ARRHYTHMIA 168 0.0035
284 SUBARACHNOID HAEMORRHAGE 36 0.0035
285 PURPURA 31 0.0035
286 THROMBOCYTOPENIA 391 0.0035
287 GASTROINTESTINAL HAEMORRHAGE 292 0.0035
288 PALPITATIONS 409 0.0035
289 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
290 HEPATITIS CHOLESTATIC 21 0.0035
291 FEELING COLD 97 0.0035
292 BLOOD THYROID STIMULATING HORMONE INCREASED 32 0.0035
293 ELECTROCARDIOGRAM QT PROLONGED 125 0.0035
294 CEREBRAL HAEMORRHAGE 124 0.0035
295 BLOOD PRESSURE DECREASED 230 0.0035
296 INTERVERTEBRAL DISC DEGENERATION 32 0.0035
297 METABOLIC DISORDER 20 0.0034
298 MOUTH HAEMORRHAGE 25 0.0034
299 ACIDOSIS 26 0.0034
300 RENAL INJURY 101 0.0034
301 VITAMIN D DECREASED 29 0.0034
302 BLOOD POTASSIUM DECREASED 102 0.0034
303 SEASONAL ALLERGY 48 0.0034
304 ENERGY INCREASED 20 0.0034
305 INTERVERTEBRAL DISC PROTRUSION 74 0.0034
306 HAIR COLOUR CHANGES 42 0.0034
307 INCREASED TENDENCY TO BRUISE 31 0.0034
308 FLUSHING 342 0.0034
309 MIOSIS 27 0.0034
310 PRODUCT PRESCRIBING ERROR 80 0.0034
311 PROTHROMBIN TIME PROLONGED 20 0.0033
312 MYOSITIS 30 0.0033
313 ONYCHOCLASIS 23 0.0033
314 SWOLLEN TONGUE 104 0.0033
315 LARGE INTESTINE POLYP 23 0.0033
316 LEUKOCYTOSIS 60 0.0033
317 HAEMOPTYSIS 92 0.0033
318 ESCHERICHIA INFECTION 27 0.0033
319 BREAST PAIN 35 0.0033
320 ACUTE RESPIRATORY DISTRESS SYNDROME 58 0.0033
321 UPPER-AIRWAY COUGH SYNDROME 27 0.0033
322 HAIR DISORDER 27 0.0033
323 BOWEL MOVEMENT IRREGULARITY 25 0.0033
324 LIPASE INCREASED 25 0.0033
325 RENAL FAILURE ACUTE 138 0.0032
326 HAEMATURIA 111 0.0032
327 HALLUCINATION, VISUAL 68 0.0032
328 FALL 1071 0.0032
329 PULMONARY OEDEMA 144 0.0032
330 DYSPEPSIA 316 0.0032
331 GLYCOSYLATED HAEMOGLOBIN INCREASED 81 0.0032
332 BLOOD CREATINE PHOSPHOKINASE INCREASED 92 0.0032
333 ROTATOR CUFF SYNDROME 41 0.0032
334 BRAIN FOG 50 0.0032
335 PARKINSONISM 31 0.0032
336 MUCOSAL INFLAMMATION 83 0.0032
337 RENAL TUBULAR NECROSIS 31 0.0032
338 CHOLECYSTECTOMY 36 0.0031
339 ATRIAL FLUTTER 25 0.0031
340 BLOOD CHOLESTEROL INCREASED 146 0.0031
341 CHEST PAIN 580 0.0031
342 MYALGIA 532 0.0031
343 MYOPATHY 27 0.0031
344 FLATULENCE 177 0.0031
345 BLOOD UREA INCREASED 52 0.0031
346 DYSPNOEA 1745 0.0031
347 NEUTROPENIC SEPSIS 22 0.0031
348 GASTRITIS 81 0.0031
349 ANGINA UNSTABLE 20 0.0031
350 SPINAL PAIN 36 0.0031
351 DIVERTICULITIS 85 0.0031
352 NEPHROTIC SYNDROME 21 0.0031
353 DERMATITIS BULLOUS 22 0.0030
354 TENDONITIS 47 0.0030
355 SCRATCH 32 0.0030
356 BLOOD CALCIUM DECREASED 34 0.0030
357 INITIAL INSOMNIA 31 0.0030
358 EAR DISCOMFORT 31 0.0030
359 HEMIPARESIS 51 0.0030
360 JAUNDICE 81 0.0030
361 HEART RATE IRREGULAR 68 0.0030
362 CARDIOMEGALY 37 0.0030
363 GINGIVAL BLEEDING 41 0.0030
364 EYE HAEMORRHAGE 40 0.0030
365 RIGHT VENTRICULAR FAILURE 21 0.0030
366 HEAD DISCOMFORT 53 0.0030
367 INTERNAL HAEMORRHAGE 34 0.0030
368 MUSCULAR WEAKNESS 338 0.0030
369 PULMONARY FIBROSIS 57 0.0030
370 DRY MOUTH 241 0.0030
371 ASTHENIA 1115 0.0030
372 DIPLOPIA 77 0.0030
373 TOXIC EPIDERMAL NECROLYSIS 45 0.0030
374 HYPOKINESIA 43 0.0030
375 CYSTITIS 94 0.0029
376 COLD SWEAT 52 0.0029
377 DYSARTHRIA 111 0.0029
378 DECUBITUS ULCER 24 0.0029
379 LEUKOPENIA 147 0.0029
380 BURNING SENSATION 206 0.0029
381 IMPAIRED GASTRIC EMPTYING 40 0.0029
382 MULTIPLE ALLERGIES 23 0.0029
383 CHEST DISCOMFORT 299 0.0029
384 ALTERED STATE OF CONSCIOUSNESS 63 0.0029
385 MUSCLE TIGHTNESS 47 0.0029
386 DYSURIA 106 0.0029
387 RESPIRATORY TRACT INFECTION 75 0.0029
388 BRONCHITIS 213 0.0029
389 HEART RATE INCREASED 285 0.0029
390 HYPERTRANSAMINASAEMIA 20 0.0029
391 DIZZINESS 1433 0.0029
392 DRUG-INDUCED LIVER INJURY 90 0.0029
393 CYTOPENIA 35 0.0029
394 CARPAL TUNNEL SYNDROME 40 0.0029
395 NIGHT SWEATS 92 0.0029
396 KIDNEY INFECTION 56 0.0029
397 HYPOTHYROIDISM 91 0.0028
398 HAIR TEXTURE ABNORMAL 38 0.0028
399 PROTEINURIA 54 0.0028
400 DIARRHOEA 1833 0.0028
401 BRONCHOPULMONARY ASPERGILLOSIS 22 0.0028
402 COMA 135 0.0028
403 PULMONARY ARTERIAL HYPERTENSION 41 0.0028
404 BLOOD GLUCOSE FLUCTUATION 31 0.0028
405 RASH ERYTHEMATOUS 134 0.0028
406 GASTROOESOPHAGEAL REFLUX DISEASE 225 0.0028
407 DIZZINESS POSTURAL 27 0.0028
408 HEAD INJURY 88 0.0028
409 BALANCE DISORDER 240 0.0028
410 FEELING HOT 170 0.0028
411 WEIGHT FLUCTUATION 29 0.0028
412 MALNUTRITION 31 0.0028
413 BLOOD PRESSURE SYSTOLIC INCREASED 54 0.0028
414 COUGH 775 0.0028
415 STAPHYLOCOCCAL INFECTION 91 0.0028
416 OEDEMA 149 0.0027
417 NIGHTMARE 95 0.0027
418 NERVOUSNESS 143 0.0027
419 INFUSION SITE ERYTHEMA 23 0.0027
420 PLEURAL EFFUSION 166 0.0027
421 DISORIENTATION 108 0.0027
422 DERMATITIS CONTACT 31 0.0027
423 LOWER GASTROINTESTINAL HAEMORRHAGE 20 0.0027
424 COAGULOPATHY 45 0.0027
425 NERVE INJURY 30 0.0027
426 SCIATICA 43 0.0027
427 GALLBLADDER DISORDER 48 0.0027
428 APHASIA 81 0.0027
429 HOT FLUSH 202 0.0027
430 MUSCLE RIGIDITY 32 0.0027
431 PRODUCT ODOUR ABNORMAL 28 0.0027
432 NEURALGIA 65 0.0027
433 LUNG DISORDER 131 0.0027
434 AFFECTIVE DISORDER 21 0.0027
435 WRIST FRACTURE 32 0.0027
436 PHOTOSENSITIVITY REACTION 44 0.0027
437 LETHARGY 153 0.0027
438 DIABETES MELLITUS INADEQUATE CONTROL 47 0.0027
439 DRUG PRESCRIBING ERROR 51 0.0027
440 WEIGHT DECREASED 739 0.0026
441 PALLOR 72 0.0026
442 HEMIPLEGIA 22 0.0026
443 OSTEOARTHRITIS 112 0.0026
444 CONFUSIONAL STATE 426 0.0026
445 RESPIRATORY FAILURE 192 0.0026
446 NECK PAIN 147 0.0026
447 EXOSTOSIS 24 0.0026
448 RETCHING 56 0.0026
449 DERMATITIS ALLERGIC 33 0.0026
450 RED BLOOD CELL COUNT DECREASED 75 0.0026
451 SEPTIC SHOCK 114 0.0026
452 DECREASED APPETITE 607 0.0026
453 TINNITUS 120 0.0026
454 PULMONARY EMBOLISM 248 0.0026
455 NERVE COMPRESSION 24 0.0026
456 ANAPHYLACTIC SHOCK 67 0.0026
457 GLAUCOMA 50 0.0026
458 MUSCULOSKELETAL PAIN 136 0.0026
459 DEHYDRATION 346 0.0026
460 ATELECTASIS 25 0.0026
461 HAEMOGLOBIN DECREASED 265 0.0026
462 FULL BLOOD COUNT DECREASED 52 0.0026
463 HYPERGLYCAEMIA 94 0.0026
464 WOUND 72 0.0026
465 RASH MACULAR 90 0.0026
466 HYPOPHOSPHATAEMIA 19 0.0026
467 AGEUSIA 64 0.0026
468 IRRITABLE BOWEL SYNDROME 55 0.0026
469 TOOTH ABSCESS 26 0.0026
470 GAIT DISTURBANCE 488 0.0025
471 DEEP VEIN THROMBOSIS 165 0.0025
472 SPINAL DISORDER 24 0.0025
473 ERUCTATION 49 0.0025
474 PLATELET COUNT INCREASED 33 0.0025
475 TYPE 2 DIABETES MELLITUS 85 0.0025
476 HEPATIC ENZYME INCREASED 172 0.0025
477 MUSCLE SPASMS 462 0.0025
478 PERIPHERAL SWELLING 386 0.0025
479 LOSS OF CONSCIOUSNESS 321 0.0025
480 ORAL PAIN 56 0.0025
481 TUMOUR LYSIS SYNDROME 22 0.0025
482 HYPERTHERMIA 19 0.0025
483 SKIN LACERATION 27 0.0025
484 ABDOMINAL DISTENSION 259 0.0025
485 CHROMATURIA 56 0.0025
486 WHEEZING 147 0.0025
487 SECRETION DISCHARGE 31 0.0025
488 INSOMNIA 659 0.0025
489 HYPOTHERMIA 25 0.0025
490 GASTROENTERITIS 36 0.0025
491 PERICARDIAL EFFUSION 57 0.0025
492 MIDDLE INSOMNIA 46 0.0025
493 FOOD ALLERGY 19 0.0025
494 FUNGAL INFECTION 82 0.0025
495 UPPER RESPIRATORY TRACT INFECTION 113 0.0024
496 FAECES DISCOLOURED 53 0.0024
497 ABDOMINAL PAIN UPPER 503 0.0024
498 VITREOUS FLOATERS 24 0.0024
499 CONTUSION 234 0.0024
500 HERNIA 47 0.0024
501 THERAPEUTIC RESPONSE UNEXPECTED 109 0.0024
502 GENERALISED OEDEMA 30 0.0024
503 HEREDITARY ANGIOEDEMA 26 0.0024
504 PARAESTHESIA 381 0.0024
505 FATIGUE 1883 0.0024
506 PANCYTOPENIA 135 0.0024
507 BONE DISORDER 44 0.0024
508 MADAROSIS 28 0.0024
509 LOCAL SWELLING 42 0.0024
510 PRODUCT SUBSTITUTION ISSUE 138 0.0024
511 BLOOD ALBUMIN DECREASED 19 0.0024
512 HAEMATOCHEZIA 132 0.0024
513 MUSCULOSKELETAL CHEST PAIN 37 0.0024
514 MALIGNANT MELANOMA 32 0.0024
515 QUALITY OF LIFE DECREASED 32 0.0024
516 PULMONARY THROMBOSIS 26 0.0024
517 CONSTIPATION 520 0.0024
518 HYPERHIDROSIS 307 0.0024
519 TACHYCARDIA 210 0.0024
520 RASH PRURITIC 128 0.0024
521 TOOTH FRACTURE 26 0.0024
522 RENAL PAIN 25 0.0024
523 FLANK PAIN 22 0.0023
524 HAEMOLYTIC ANAEMIA 21 0.0023
525 SKIN REACTION 33 0.0023
526 HEPATOMEGALY 23 0.0023
527 FLUID RETENTION 119 0.0023
528 URINARY TRACT INFECTION 397 0.0023
529 SKIN ULCER 60 0.0023
530 RENAL DISORDER 108 0.0023
531 DYSPHAGIA 220 0.0023
532 HEADACHE 1451 0.0023
533 TREMOR 384 0.0023
534 OSTEOPENIA 35 0.0023
535 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 22 0.0023
536 CARDIAC FAILURE CONGESTIVE 185 0.0023
537 DYSSTASIA 67 0.0023
538 PAIN IN EXTREMITY 673 0.0023
539 ABDOMINAL PAIN 530 0.0023
540 GROIN PAIN 20 0.0023
541 CARDIAC ARREST 188 0.0023
542 BACK DISORDER 37 0.0023
543 SLEEP DISORDER 160 0.0023
544 PRURITUS GENERALISED 49 0.0023
545 LYMPHOPENIA 32 0.0023
546 DISTURBANCE IN ATTENTION 122 0.0023
547 FEELING JITTERY 43 0.0023
548 SLUGGISHNESS 23 0.0023
549 POLLAKIURIA 94 0.0023
550 FACE OEDEMA 38 0.0023
551 PANCREATITIS 119 0.0022
552 INFUSION SITE PAIN 29 0.0022
553 METASTASES TO LUNG 26 0.0022
554 CANDIDA INFECTION 38 0.0022
555 PROSTATIC SPECIFIC ANTIGEN INCREASED 31 0.0022
556 ABNORMAL DREAMS 62 0.0022
557 ASCITES 66 0.0022
558 SINUSITIS 230 0.0022
559 NEUTROPENIA 305 0.0022
560 COELIAC DISEASE 22 0.0022
561 COLITIS 85 0.0022
562 ENCEPHALOPATHY 55 0.0022
563 LACERATION 21 0.0022
564 CARDIOMYOPATHY 33 0.0022
565 INFLAMMATION 115 0.0022
566 SKIN HAEMORRHAGE 33 0.0022
567 DRY EYE 111 0.0022
568 SEPSIS 248 0.0022
569 OSTEONECROSIS OF JAW 55 0.0022
570 PRODUCT TASTE ABNORMAL 30 0.0022
571 BLADDER DISORDER 22 0.0022
572 FOOT FRACTURE 42 0.0022
573 BLOOD URINE PRESENT 42 0.0022
574 SOMNOLENCE 445 0.0022
575 MUSCLE ATROPHY 28 0.0022
576 BACK PAIN 513 0.0022
577 BACK INJURY 24 0.0022
578 PNEUMONITIS 60 0.0022
579 ORAL CANDIDIASIS 29 0.0022
580 VISUAL ACUITY REDUCED 73 0.0022
581 NEUROPATHY PERIPHERAL 209 0.0022
582 CHOLELITHIASIS 72 0.0022
583 LIP SWELLING 73 0.0022
584 BLOOD IRON DECREASED 26 0.0022
585 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 51 0.0022
586 POOR QUALITY SLEEP 47 0.0022
587 CHOLECYSTITIS 26 0.0022
588 DYSGEUSIA 162 0.0022
589 NEOPLASM 25 0.0022
590 PNEUMONIA 704 0.0022
591 ARTHRITIS 171 0.0022
592 WEIGHT INCREASED 486 0.0022
593 BLOOD CALCIUM INCREASED 19 0.0022
594 FOOT DEFORMITY 24 0.0022
595 DRY THROAT 22 0.0022
596 HALLUCINATION 163 0.0022
597 VENTRICULAR FIBRILLATION 24 0.0022
598 URINARY INCONTINENCE 64 0.0022
599 LOWER RESPIRATORY TRACT INFECTION 98 0.0022
600 SINUS CONGESTION 29 0.0021
601 PNEUMOTHORAX 34 0.0021
602 C-REACTIVE PROTEIN INCREASED 78 0.0021
603 ADRENAL INSUFFICIENCY 26 0.0021
604 NEPHROPATHY TOXIC 24 0.0021
605 OCULAR DISCOMFORT 24 0.0021
606 DYSPHONIA 125 0.0021
607 THERAPY CHANGE 21 0.0021
608 CATARACT 127 0.0021
609 ANKLE FRACTURE 33 0.0021
610 EYE DISORDER 70 0.0021
611 HYPERSOMNIA 61 0.0021
612 DRUG INTOLERANCE 205 0.0021
613 GASTROINTESTINAL INFECTION 19 0.0021
614 ABDOMINAL DISCOMFORT 355 0.0021
615 PRODUCTIVE COUGH 101 0.0021
616 NEPHROLITHIASIS 97 0.0021
617 JOINT INJURY 45 0.0021
618 SCAB 24 0.0021
619 LIMB DISCOMFORT 65 0.0021
620 TOOTHACHE 38 0.0021
621 MALAISE 919 0.0021
622 MYOCARDITIS 24 0.0021
623 MACULAR DEGENERATION 25 0.0021
624 HAEMATEMESIS 53 0.0021
625 THERAPY CESSATION 107 0.0021
626 FEBRILE NEUTROPENIA 138 0.0021
627 JOINT SWELLING 250 0.0021
628 THIRST 37 0.0021
629 SINUS DISORDER 41 0.0021
630 LYMPHADENOPATHY 73 0.0021
631 NAUSEA 1632 0.0021
632 STOMATITIS 125 0.0021
633 ABDOMINAL PAIN LOWER 52 0.0021
634 LIVER FUNCTION TEST INCREASED 44 0.0020
635 RASH GENERALISED 53 0.0020
636 SUICIDE ATTEMPT 124 0.0020
637 BLOOD COUNT ABNORMAL 31 0.0020
638 RESPIRATORY DISTRESS 56 0.0020
639 HOSPICE CARE 20 0.0020
640 AMNESIA 131 0.0020
641 COGNITIVE DISORDER 94 0.0020
642 GASTRIC DISORDER 69 0.0020
643 SKIN LESION 55 0.0020
644 TRANSFUSION 21 0.0020
645 VISION BLURRED 275 0.0020
646 GASTROINTESTINAL PAIN 22 0.0020
647 ALOPECIA 392 0.0020
648 SENSORY DISTURBANCE 32 0.0020
649 RIB FRACTURE 41 0.0020
650 BLOOD TEST ABNORMAL 28 0.0020
651 APATHY 29 0.0020
652 PRODUCT PHYSICAL ISSUE 40 0.0020
653 FEELING ABNORMAL 475 0.0020
654 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 141 0.0020
655 CONTRAINDICATED PRODUCT ADMINISTERED 60 0.0020
656 POST PROCEDURAL HAEMORRHAGE 23 0.0020
657 PRURITUS 759 0.0020
658 PULMONARY CONGESTION 26 0.0020
659 SKIN DISCOLOURATION 90 0.0020
660 DERMATITIS 41 0.0020
661 COMPLETED SUICIDE 163 0.0020
662 HYPOPHAGIA 50 0.0020
663 ANXIETY 556 0.0020
664 PHARYNGEAL OEDEMA 30 0.0019
665 INTENTIONAL OVERDOSE 125 0.0019
666 SPINAL OPERATION 24 0.0019
667 AGITATION 143 0.0019
668 CEREBROVASCULAR ACCIDENT 329 0.0019
669 ATAXIA 23 0.0019
670 ARTHRALGIA 805 0.0019
671 COORDINATION ABNORMAL 27 0.0019
672 DELUSION 30 0.0019
673 HYPOAESTHESIA 289 0.0019
674 INTENTIONAL PRODUCT MISUSE 169 0.0019
675 SPEECH DISORDER 101 0.0019
676 HYPOAESTHESIA ORAL 29 0.0019
677 OXYGEN SATURATION DECREASED 108 0.0019
678 VOMITING 902 0.0019
679 UVEITIS 26 0.0019
680 HEPATIC CIRRHOSIS 36 0.0019
681 BLINDNESS UNILATERAL 27 0.0019
682 EYE SWELLING 71 0.0019
683 CYANOSIS 30 0.0019
684 LOCALISED INFECTION 46 0.0019
685 MEMORY IMPAIRMENT 261 0.0019
686 IMMUNE SYSTEM DISORDER 25 0.0019
687 SPINAL FRACTURE 38 0.0019
688 OSTEOPOROSIS 78 0.0019
689 CHILLS 222 0.0019
690 PANIC ATTACK 69 0.0019
691 INCONTINENCE 20 0.0019
692 SWELLING FACE 123 0.0019
693 COVID-19 331 0.0019
694 THROAT TIGHTNESS 51 0.0019
695 INCREASED APPETITE 36 0.0019
696 EYE PAIN 106 0.0019
697 LIMB INJURY 51 0.0019
698 SURGERY 110 0.0019
699 RASH PAPULAR 42 0.0019
700 DEPRESSED MOOD 99 0.0019
701 PARAESTHESIA ORAL 27 0.0019
702 JOINT STIFFNESS 49 0.0019
703 MUSCLE TWITCHING 43 0.0019
704 HYPOACUSIS 80 0.0019
705 PRESCRIBED UNDERDOSE 37 0.0019
706 PHARYNGITIS 23 0.0019
707 BLOOD BILIRUBIN INCREASED 50 0.0018
708 THROAT IRRITATION 83 0.0018
709 PYREXIA 636 0.0018
710 HIP FRACTURE 59 0.0018
711 HYPERBILIRUBINAEMIA 19 0.0018
712 INTENTIONAL SELF-INJURY 37 0.0018
713 GASTROENTERITIS VIRAL 33 0.0018
714 ASPARTATE AMINOTRANSFERASE INCREASED 97 0.0018
715 BEDRIDDEN 24 0.0018
716 DEMENTIA 51 0.0018
717 TOOTH INFECTION 24 0.0018
718 LACRIMATION INCREASED 55 0.0018
719 WRONG TECHNIQUE IN DRUG USAGE PROCESS 66 0.0018
720 MENTAL IMPAIRMENT 44 0.0018
721 ERYTHEMA 373 0.0018
722 OCULAR HYPERAEMIA 86 0.0018
723 HERPES ZOSTER 104 0.0018
724 FEMUR FRACTURE 56 0.0018
725 PHOTOPHOBIA 34 0.0018
726 VISUAL IMPAIRMENT 224 0.0018
727 NO THERAPEUTIC RESPONSE 22 0.0018
728 MIGRAINE 172 0.0018
729 PRODUCT AVAILABILITY ISSUE 41 0.0018
730 TRANSAMINASES INCREASED 40 0.0018
731 SPLENOMEGALY 21 0.0018
732 CONDITION AGGRAVATED 544 0.0018
733 SMALL INTESTINAL OBSTRUCTION 22 0.0018
734 DISCOMFORT 109 0.0018
735 UNEVALUABLE EVENT 135 0.0018
736 SHOCK 41 0.0018
737 BLISTER 100 0.0018
738 PRODUCT USE COMPLAINT 28 0.0018
739 BONE PAIN 104 0.0018
740 PSORIATIC ARTHROPATHY 72 0.0018
741 CARDIO-RESPIRATORY ARREST 74 0.0018
742 TOOTH EXTRACTION 22 0.0018
743 EAR INFECTION 47 0.0018
744 INSURANCE ISSUE 27 0.0018
745 ULCER 28 0.0018
746 PRESCRIBED OVERDOSE 34 0.0018
747 CARDIAC DISORDER 164 0.0018
748 PSYCHOMOTOR HYPERACTIVITY 29 0.0017
749 INTENTIONAL PRODUCT USE ISSUE 153 0.0017
750 CLOSTRIDIUM DIFFICILE INFECTION 38 0.0017
751 IMPAIRED QUALITY OF LIFE 25 0.0017
752 HAEMORRHAGE INTRACRANIAL 26 0.0017
753 LUNG INFECTION 27 0.0017
754 MYOCARDIAL INFARCTION 302 0.0017
755 NERVOUS SYSTEM DISORDER 54 0.0017
756 FEEDING DISORDER 35 0.0017
757 TASTE DISORDER 35 0.0017
758 INTRAOCULAR PRESSURE INCREASED 22 0.0017
759 PNEUMONIA ASPIRATION 43 0.0017
760 WHITE BLOOD CELL COUNT INCREASED 66 0.0017
761 HEPATITIS 44 0.0017
762 GASTROINTESTINAL DISORDER 154 0.0017
763 DIABETES MELLITUS 131 0.0017
764 DEPRESSION 389 0.0017
765 TOOTH DISORDER 38 0.0017
766 DEVICE OCCLUSION 24 0.0017
767 HYPOXIA 60 0.0017
768 DRUG DOSE OMISSION 281 0.0017
769 ALANINE AMINOTRANSFERASE INCREASED 104 0.0017
770 DIALYSIS 24 0.0017
771 SWELLING 157 0.0017
772 FEAR 45 0.0017
773 RHINORRHOEA 108 0.0017
774 INFLUENZA 186 0.0017
775 RESTLESSNESS 61 0.0017
776 MUSCULOSKELETAL STIFFNESS 145 0.0017
777 EXPIRED PRODUCT ADMINISTERED 55 0.0017
778 OROPHARYNGEAL PAIN 153 0.0017
779 GLOSSODYNIA 37 0.0017
780 HUNGER 23 0.0016
781 RASH 719 0.0016
782 DYSKINESIA 67 0.0016
783 INTENTIONAL DOSE OMISSION 47 0.0016
784 CELLULITIS 83 0.0016
785 IMPAIRED HEALING 54 0.0016
786 PLATELET COUNT DECREASED 175 0.0016
787 SEDATION 43 0.0016
788 RESPIRATORY DISORDER 49 0.0016
789 EPILEPSY 50 0.0016
790 PRODUCT ADMINISTRATION ERROR 33 0.0016
791 GENERALISED TONIC-CLONIC SEIZURE 27 0.0016
792 INFLUENZA LIKE ILLNESS 134 0.0016
793 PAIN IN JAW 46 0.0016
794 PRODUCT DOSE OMISSION 106 0.0016
795 THYROID DISORDER 25 0.0016
796 MOVEMENT DISORDER 52 0.0016
797 ASTHMA 183 0.0016
798 HEPATOTOXICITY 36 0.0016
799 LIVER FUNCTION TEST ABNORMAL 47 0.0016
800 CARDIOVASCULAR DISORDER 41 0.0016
801 SEIZURE 186 0.0016
802 MENTAL DISORDER 70 0.0016
803 FIBROMYALGIA 39 0.0016
804 EYE IRRITATION 92 0.0016
805 SKIN FISSURES 31 0.0016
806 METASTASES TO BONE 26 0.0016
807 FLUID OVERLOAD 23 0.0016
808 SKIN CANCER 34 0.0016
809 BLOOD LACTATE DEHYDROGENASE INCREASED 25 0.0016
810 MOUTH ULCERATION 33 0.0016
811 JOINT RANGE OF MOTION DECREASED 21 0.0016
812 BLOOD GLUCOSE INCREASED 295 0.0016
813 NASAL CONGESTION 92 0.0016
814 THROMBOSIS 125 0.0016
815 SINUS TACHYCARDIA 22 0.0015
816 MEDICATION ERROR 86 0.0015
817 BLOOD GLUCOSE DECREASED 74 0.0015
818 ORAL HERPES 30 0.0015
819 METASTASES TO LIVER 27 0.0015
820 DRUG ADMINISTRATION ERROR 47 0.0015
821 CYST 19 0.0015
822 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
823 BONE MARROW FAILURE 31 0.0015
824 ANAPHYLACTIC REACTION 84 0.0015
825 KNEE ARTHROPLASTY 32 0.0015
826 SNEEZING 34 0.0015
827 THERAPY NON-RESPONDER 68 0.0015
828 HAEMORRHAGE 158 0.0015
829 PSORIASIS 197 0.0015
830 ROAD TRAFFIC ACCIDENT 63 0.0015
831 EATING DISORDER 32 0.0015
832 HIP ARTHROPLASTY 23 0.0015
833 CYTOKINE RELEASE SYNDROME 30 0.0015
834 BLOOD ALKALINE PHOSPHATASE INCREASED 37 0.0015
835 DRUG EFFECT LESS THAN EXPECTED 22 0.0015
836 UNRESPONSIVE TO STIMULI 38 0.0015
837 OFF LABEL USE 1289 0.0015
838 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 298 0.0015
839 URTICARIA 246 0.0015
840 GAIT INABILITY 49 0.0015
841 ACTIVITIES OF DAILY LIVING IMPAIRED 29 0.0015
842 HYPERSENSITIVITY 271 0.0015
843 DRUG EFFECT INCOMPLETE 53 0.0015
844 ARTHROPATHY 81 0.0015
845 PAIN 895 0.0015
846 ECZEMA 76 0.0015
847 RESPIRATORY TRACT CONGESTION 23 0.0014
848 NEUTROPHIL COUNT DECREASED 59 0.0014
849 OBESITY 23 0.0014
850 DELIRIUM 50 0.0014
851 EAR PAIN 28 0.0014
852 TOXICITY TO VARIOUS AGENTS 242 0.0014
853 EYE PRURITUS 48 0.0014
854 NASOPHARYNGITIS 260 0.0014
855 SKIN EXFOLIATION 119 0.0014
856 THERAPY PARTIAL RESPONDER 22 0.0014
857 DISEASE RECURRENCE 67 0.0014
858 INTESTINAL OBSTRUCTION 53 0.0014
859 LOWER LIMB FRACTURE 27 0.0014
860 PARALYSIS 20 0.0014
861 THINKING ABNORMAL 26 0.0014
862 PROCEDURAL PAIN 38 0.0014
863 IMPAIRED WORK ABILITY 29 0.0014
864 DRUG ERUPTION 24 0.0014
865 BLOOD GLUCOSE ABNORMAL 25 0.0014
866 SKIN DISORDER 45 0.0013
867 CONJUNCTIVITIS 25 0.0013
868 INFECTION 195 0.0013
869 ABASIA 33 0.0013
870 MOBILITY DECREASED 95 0.0013
871 HALLUCINATION, AUDITORY 21 0.0013
872 CRYING 48 0.0013
873 WHITE BLOOD CELL COUNT DECREASED 143 0.0013
874 MUSCULOSKELETAL DISORDER 25 0.0013
875 DISEASE PROGRESSION 155 0.0013
876 DRUG ABUSE 109 0.0013
877 DRUG DISPENSING ERROR 20 0.0013
878 LYMPHOCYTE COUNT DECREASED 23 0.0013
879 DEAFNESS 34 0.0013
880 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 62 0.0013
881 LIVER DISORDER 57 0.0013
882 SCAR 22 0.0013
883 PRODUCT USE ISSUE 240 0.0013
884 COLON CANCER 19 0.0013
885 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
886 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 90 0.0013
887 DRUG EFFECT DECREASED 68 0.0013
888 VIRAL INFECTION 42 0.0013
889 GYNAECOMASTIA 39 0.0013
890 DRUG INEFFECTIVE 1660 0.0013
891 ECONOMIC PROBLEM 19 0.0013
892 APPLICATION SITE PRURITUS 28 0.0012
893 BACTERIAL INFECTION 23 0.0012
894 MALIGNANT NEOPLASM PROGRESSION 126 0.0012
895 CHOKING 24 0.0012
896 MENTAL STATUS CHANGES 34 0.0012
897 SUICIDAL IDEATION 112 0.0012
898 PRODUCT QUALITY ISSUE 166 0.0012
899 LABORATORY TEST ABNORMAL 36 0.0012
900 ANHEDONIA 32 0.0012
901 DEPRESSED LEVEL OF CONSCIOUSNESS 48 0.0012
902 PLASMA CELL MYELOMA 47 0.0012
903 UPPER LIMB FRACTURE 24 0.0012
904 ADVERSE DRUG REACTION 108 0.0012
905 IRRITABILITY 71 0.0012
906 ACCIDENTAL OVERDOSE 43 0.0012
907 ILLNESS 121 0.0012
908 INCORRECT DRUG ADMINISTRATION DURATION 33 0.0012
909 MOOD ALTERED 32 0.0012
910 TREATMENT NONCOMPLIANCE 64 0.0012
911 STEVENS-JOHNSON SYNDROME 26 0.0012
912 HEPATIC FAILURE 35 0.0012
913 PRODUCT USE IN UNAPPROVED INDICATION 286 0.0012
914 DRY SKIN 154 0.0012
915 THERAPY INTERRUPTED 82 0.0011
916 CEREBRAL INFARCTION 28 0.0011
917 POST PROCEDURAL COMPLICATION 22 0.0011
918 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 62 0.0011
919 FRACTURE 21 0.0011
920 THERAPEUTIC RESPONSE DECREASED 67 0.0011
921 PRODUCT DISPENSING ERROR 24 0.0011
922 MULTIPLE ORGAN DYSFUNCTION SYNDROME 31 0.0011
923 NEOPLASM PROGRESSION 38 0.0011
924 THERAPEUTIC RESPONSE SHORTENED 36 0.0011
925 PAIN OF SKIN 29 0.0011
926 FREQUENT BOWEL MOVEMENTS 29 0.0011
927 WITHDRAWAL SYNDROME 45 0.0011
928 CONVULSION 61 0.0011
929 ANGER 36 0.0011
930 BLINDNESS 43 0.0011
931 DRUG RESISTANCE 27 0.0011
932 PRODUCT DOSE OMISSION ISSUE 302 0.0010
933 LUNG NEOPLASM MALIGNANT 42 0.0010
934 PERITONITIS 21 0.0010
935 DISABILITY 20 0.0010
936 INJECTION SITE RASH 31 0.0010
937 ABNORMAL BEHAVIOUR 40 0.0010
938 SKIN BURNING SENSATION 72 0.0010
939 INJECTION SITE BRUISING 80 0.0010
940 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 180 0.0010
941 RESPIRATORY ARREST 27 0.0010
942 THERAPEUTIC PRODUCT EFFECT DECREASED 43 0.0010
943 RHEUMATOID ARTHRITIS 109 0.0010
944 INCORRECT DOSE ADMINISTERED 216 0.0009
945 HOSPITALISATION 142 0.0009
946 UNDERDOSE 67 0.0009
947 APPLICATION SITE ERYTHEMA 24 0.0009
948 MOOD SWINGS 29 0.0009
949 INJECTION SITE URTICARIA 22 0.0009
950 INJECTION SITE PRURITUS 60 0.0009
951 INJECTION SITE HAEMORRHAGE 71 0.0009
952 ILL-DEFINED DISORDER 54 0.0009
953 EMOTIONAL DISORDER 27 0.0009
954 INJECTION SITE MASS 32 0.0009
955 EXTRA DOSE ADMINISTERED 35 0.0009
956 APPLICATION SITE PAIN 19 0.0009
957 MULTIPLE SCLEROSIS RELAPSE 59 0.0009
958 ADVERSE EVENT 77 0.0008
959 INFUSION RELATED REACTION 55 0.0008
960 VAGINAL HAEMORRHAGE 36 0.0008
961 OVERDOSE 177 0.0008
962 AGGRESSION 41 0.0008
963 INJECTION SITE ERYTHEMA 101 0.0008
964 INJECTION SITE PAIN 248 0.0008
965 MULTIPLE SCLEROSIS 38 0.0008
966 PRODUCT ADHESION ISSUE 28 0.0008
967 COLITIS ULCERATIVE 35 0.0008
968 PSYCHOTIC DISORDER 23 0.0008
969 PANCREATIC CARCINOMA 22 0.0008
970 INJURY 53 0.0008
971 INJECTION SITE REACTION 51 0.0007
972 DEVICE MALFUNCTION 52 0.0007
973 DEVICE ISSUE 65 0.0007
974 DERMATITIS ATOPIC 37 0.0007
975 INJECTION SITE SWELLING 52 0.0007
976 DEATH 582 0.0007
977 NEOPLASM MALIGNANT 45 0.0007
978 EMOTIONAL DISTRESS 77 0.0006
979 RENAL CANCER 30 0.0006
980 SKIN IRRITATION 28 0.0006
981 BREAST CANCER 55 0.0006
982 ACNE 43 0.0006
983 PROSTATE CANCER 44 0.0005
984 DEVICE DISLOCATION 23 0.0005
985 TREATMENT FAILURE 42 0.0005
986 PRODUCT STORAGE ERROR 42 0.0005
987 FOETAL EXPOSURE DURING PREGNANCY 37 0.0005
988 NO ADVERSE EVENT 82 0.0005
989 DRUG WITHDRAWAL SYNDROME 38 0.0004
990 ACCIDENTAL EXPOSURE TO PRODUCT 44 0.0004
991 MATERNAL EXPOSURE DURING PREGNANCY 21 0.0002
992 DRUG DEPENDENCE 37 0.0002